- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1747-1028
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Principles of dormancy evident in high-grade serous ovarian cancer ; volume:17 ; number:1 ; day:23 ; month:3 ; year:2022 ; pages:1-11 ; date:12.2022
Cell division ; 17, Heft 1 (23.3.2022), 1-11, 12.2022
- Creator
-
Shepherd, Trevor G.
Dick, Frederick A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13008-022-00079-y
- URN
-
urn:nbn:de:101:1-2022061421414796175374
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shepherd, Trevor G.
- Dick, Frederick A.
- SpringerLink (Online service)
Other Objects (12)
High-grade serous ovarian cancer: the clone wars
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
No evidence for PALB2 methylation in high-grade serous ovarian cancer
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma
High-throughput approaches for precision medicine in high-grade serous ovarian cancer
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
Immune cell landscapes are associated with high-grade serous ovarian cancer survival
High-grade serous ovarian cancer: the clone wars
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
No evidence for PALB2 methylation in high-grade serous ovarian cancer
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma
High-throughput approaches for precision medicine in high-grade serous ovarian cancer
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
Immune cell landscapes are associated with high-grade serous ovarian cancer survival
High-grade serous ovarian cancer: the clone wars
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
No evidence for PALB2 methylation in high-grade serous ovarian cancer
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma
High-throughput approaches for precision medicine in high-grade serous ovarian cancer
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer